Washington Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 24 (89% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 15,070
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 62.30%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 2,061
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 65.37%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 33.54% 31.20%
White, Hispanic/Latino Patients 23.88% 24.89%
Black/African American, Non-Hispanic/Latino Patients 2.13% 2.04%
Black/African American, Hispanic/Latino Patients 0.11% 0.19%
Asian Patients3 2.21% 1.36%
American Indian/Alaska Native Patients3 3.48% 3.74%
Native Hawaiian/Other Pacific Islander Patients3 0.60% 0.73%
Patients with More than one race3 12.41% 12.18%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 10.60% 13.78%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.97% 1.75%
Unreported/Refused to Report Race and Ethnicity 9.07% 8.15%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 7,180
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 72.22%
COVID-19 Immunization Series Completed 6,017
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 67.61%
COVID-19 Immunization Series Additional 739
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 38.94%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 25.33% 29.18% 56.02%
White, Hispanic/Latino Patients 20.00% 23.85% 8.66%
Black/African American, Non-Hispanic/Latino Patients 4.37% 5.87% 0.95%
Black/African American, Hispanic/Latino Patients 0.19% 0.18% 0.27%
Asian Patients3 3.12% 5.02% 10.42%
American Indian/Alaska Native Patients3 1.96% 2.39% 0.68%
Native Hawaiian/Other Pacific Islander Patients3 0.91% 1.45% 0.54%
Patients with More than one race3 23.69% 6.38% 13.67%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 11.62% 15.77% 0.54%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.20% 3.34% 1.62%
Unreported/Refused to Report Race and Ethnicity 5.60% 6.56% 6.63%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 8.33%
1 to 24 Hours 20.83%
More Than 24 Hours 66.67%
N/A 4.17%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 8.33%
Staffing to administer the vaccine 33.33%
Vaccine confidence 54.17%
Vaccine storage capacity 4.17%
Vaccine supply 4.17%
Other 25.00%
None 25.00%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 91.04%
Average Percent of Health Center Visits Conducted Virtually 14.37%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 37.50%
Number of Mobile Van Sites 8
Number of Pop-up Clinics 21
Number of School-Based Vaccination Sites 12

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 33.33%
None 66.67%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 16.67%
Patient awareness/education 4.17%
Staffing capacity 33.33%
Therapy administration/onsite logistics 12.50%
Other 29.17%
None 33.33%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021